Commission Regulation (EC) No 249/2009 of 23 March 2009 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
072/2011
In force in the EEA
Yes
Legal Documents
Commission Regulation (EC) No 249/2009 of 23 March 2009 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate
Reglugerð framkvæmdastjórnarinnar (EB) nr. 249/2009 frá 23. mars 2009 um breytingu á reglugerð ráðsins (EB) nr. 297/95 að því er varðar aðlögun á gjöldum til Lyfjastofnunar Evrópu með tilliti til verðbólgu
Verordnung (EG) Nr. 249/2009 der Kommission vom 23. März 2009 zur Änderung der Verordnung (EG) Nr. 297/95 des Rates zwecks Anpassung der Gebühren der Europäischen Arzneimittel-Agentur an die Inflationsrate
Kommisjonsforordning (EF) nr. 249/2009 av 23. mars 2009 om endring av rådsforordning (EF) nr. 297/95 med hensyn til justering etter inflasjonstakten av gebyrene til Det europeiske legemiddelkontor
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.